 | • レポートコード：MRC2304L134 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、244ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、世界のレジオネラ検査市場規模が2021年に299.58百万ドル、2022年に325.64百万ドルとなり、その後2027年までにCAGR 8.87％で成長して498.99百万ドルに達すると予測しています。当書は、レジオネラ検査の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、検査別分析（培養方法、直接蛍光抗体検査、核酸ベース検出、血清検査、尿中抗原検査）、用途別分析（臨床試験、環境試験）、エンドユーザー別分析（診断検査室、病院＆クリニック）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。また、当書には、Albagaia Ltd.、Alere, Inc.、Aquacert Ltd.、Beckman Coulter, Inc.、Becton, Dickinson, and Company、Bio-Rad Laboratories, Inc、bioMérieux SA、Eiken Chemical Co., Ltd、Hologic, Inc.、IDEXX Laboratories, Inc.、Merck KGaA、PACIFIC WATER TECHNOLOGY PTY LTDなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のレジオネラ検査市場規模：検査別 - 培養方法の市場規模 - 直接蛍光抗体検査の市場規模 - 核酸ベース検出の市場規模 - 血清検査の市場規模 - 尿中抗原検査の市場規模 ・世界のレジオネラ検査市場規模：用途別 - 臨床試験における市場規模 - 環境試験における市場規模 ・世界のレジオネラ検査市場規模：エンドユーザー別 - 診断検査室における市場規模 - 病院＆クリニックにおける市場規模 ・世界のレジオネラ検査市場規模：地域別 - 南北アメリカのレジオネラ検査市場規模 アメリカのレジオネラ検査市場規模 カナダのレジオネラ検査市場規模 ブラジルのレジオネラ検査市場規模 ... - アジア太平洋のレジオネラ検査市場規模 日本のレジオネラ検査市場規模 中国のレジオネラ検査市場規模 インドのレジオネラ検査市場規模 韓国のレジオネラ検査市場規模 台湾のレジオネラ検査市場規模 ... - ヨーロッパ/中東/アフリカのレジオネラ検査市場規模 イギリスのレジオネラ検査市場規模 ドイツのレジオネラ検査市場規模 フランスのレジオネラ検査市場規模 ロシアのレジオネラ検査市場規模 ... - その他地域のレジオネラ検査市場規模 ・競争状況 ・企業情報 |
The Global Legionella Testing Market size was estimated at USD 299.58 million in 2021 and expected to reach USD 325.64 million in 2022, and is projected to grow at a CAGR 8.87% to reach USD 498.99 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Legionella Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test, the market was studied across Culture Methods, Direct Fluorescent Antibody Test, Nucleic Acid-based Detection, Serology, and Urinary Antigen Test.
Based on Application, the market was studied across Clinical Testing Methods and Environmental Testing Methods.
Based on End User, the market was studied across Diagnostic Laboratories and Hospitals and Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Legionella Testing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Legionella Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Legionella Testing Market, including Albagaia Ltd., Alere, Inc., Aquacert Ltd., Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, bioMérieux SA, Eiken Chemical Co., Ltd, Hologic, Inc., IDEXX Laboratories, Inc., Merck KGaA, PACIFIC WATER TECHNOLOGY PTY LTD, Phigenics LLC, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Legionella Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Legionella Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Legionella Testing Market?
4. What is the competitive strategic window for opportunities in the Global Legionella Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Legionella Testing Market?
6. What is the market share of the leading vendors in the Global Legionella Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Legionella Testing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of legionella-related disorders
5.1.1.2. Increasing demand by the industries for accurate and on-time diagnosis
5.1.1.3. Rising importance of water testing activities in many industries
5.1.1.4. Stringent relations for monitoring water reservoir
5.1.2. Restraints
5.1.2.1. Issues in sensitivity of diagnostic tests
5.1.2.2. High cost associated with the test
5.1.3. Opportunities
5.1.3.1. Technological advancement in DNA testing
5.1.3.2. Advent of rapid next-generation HPC testing for water
5.1.4. Challenges
5.1.4.1. Lack of sufficient diagnostic infrastructure
5.2. Cumulative Impact of COVID-19
6. Legionella Testing Market, by Test
6.1. Introduction
6.2. Culture Methods
6.3. Direct Fluorescent Antibody Test
6.4. Nucleic Acid-based Detection
6.5. Serology
6.6. Urinary Antigen Test
7. Legionella Testing Market, by Application
7.1. Introduction
7.2. Clinical Testing Methods
7.3. Environmental Testing Methods
8. Legionella Testing Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals and Clinics
9. Americas Legionella Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Legionella Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Legionella Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Albagaia Ltd.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Alere, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Aquacert Ltd.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Beckman Coulter, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Becton, Dickinson, and Company
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Bio-Rad Laboratories, Inc
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. bioMérieux SA
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Eiken Chemical Co., Ltd
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Hologic, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. IDEXX Laboratories, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Merck KGaA
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. PACIFIC WATER TECHNOLOGY PTY LTD
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Phigenics LLC
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Thermo Fisher Scientific, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing